12.9 C
New York
Sunday, April 11, 2021

CATEGORY

Business

Emergent BioSolutions [NYSE: EBS] Reaffirms 2021 Financial Guidance

Emergent BioSolutions Inc. has confirmed the business guidance for 2021. US-based drug manufacturer asserted that it would proceed with its manufacturing pacts linked...

Bank of America [NYSE: BAC] Buys Axia Technologies

Bank of America Corporation disclosed that it has bought Axia Technologies, Inc (AxiaMed). Since its inception, AxiaMed offers a portal and terminal software...

Moderna [NASDAQ: MRNA] Gives Storage Update of its COVID-19 Vaccine

Moderna Inc. disclosed that its COVID-19 vaccine has been granted the authorization by FDA to be stored at room temperature conditions once separated...

NIO [NYSE: NIO] Announces March and First Quarter 2021 Delivery Update

NIO Limited reported the update about the vehicle's delivery in the First Quarter of 2021 and in the month of March. NIO has...

BeyondSpring [NASDAQ: BYSI] Submits NDA to FDA for Plinabulin and G-CSF Combination

BeyondSpring Inc. disclosed that it has submitted a New Drug Application to the US FDA and China National Medical Products Administration (NMPA). The...

Hyatt Hotels [NYSE: H] Intends to Grow its Brand Footprint in India

Hyatt Hotels Corporation disclosed that it has decided to expand its business and reinforce its position by establishing its footprint in India. Hyatt...

Genmab [NASDAQ: GMAB] Gets European Marketing Authorization for Kesimpta

Genmab A/S disclosed Tuesday that its Kesimpta has been awarded EMA by EC for the cure of relapsing forms of multiple sclerosis (RMS)...

Johnson & Johnson [NYSE: JNJ] Inks Supply Deal of up to $400M Doses of COVID-19

Johnson & Johnson disclosed that one of the Janssen Pharmaceutical Firms of Janssen Pharmaceutica NV inked a deal with the AVATT. The supply...

QIAGEN [NYSE: QGEN] Gets FDA EUA for NeuMoDx

QIAGEN N.V. revealed that it has obtained EUA from FDA for NeuMoDx Flu A-B/RSV/SARS-CoV-2. NeuMoDx will assist health-care experts in rapidly recognize and...

Seagen [NASDAQ: SGEN] Announces Enfortumab Vedotin’s MAA to be Reviewed by EMA

Seagen Inc. and Astellas Pharma Inc both revealed Friday that Enfortumab vedotin’s MAA has received the approval of EMA. The firms have submitted...

Latest news